Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Novartis N Ord (0QLR)

Price 86.725 on 28-03-2024 at 09:25:33
Change 0.09 0.1%
Buy 88.89
Sell 84.56
Buy / Sell 0QLR Shares
Last Trade: Buy 236.00 at 87.12
Day's Volume: 6,618
Last Close: 86.635
Open: 86.59
ISIN: CH0012005267
Day's Range 84.43 - 86.725
52wk Range: 81.45 - 94.15
Market Capitalisation: -
VWAP: 87.05019
Shares in Issue: 2,044m

Recent Trades History Novartis N Ord (0QLR)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 236 87.12 SI Trade
09:25:32 - 28-Mar-24
Buy* 646 87.11 SI Trade
09:25:29 - 28-Mar-24
Buy* 48 87.03 SI Trade
09:20:17 - 28-Mar-24
Buy* 457 87.04 SI Trade
09:19:49 - 28-Mar-24
Buy* 508 87.03 SI Trade
09:19:02 - 28-Mar-24
Buy* 100 87.00 Suspected BUY Trade
09:16:51 - 28-Mar-24
Buy* 369 87.00 SI Trade
09:16:00 - 28-Mar-24
Buy* 77 87.03 SI Trade
09:12:54 - 28-Mar-24
Unknown* 0 87.05 SI Trade
09:10:23 - 28-Mar-24
Buy* 347 87.05 SI Trade
09:10:17 - 28-Mar-24

Share Price History for Novartis N Ord

Time period:
to
Date Open High Low Close Volume

Share News for Novartis N Ord

TOP NEWS: GlaxoSmithKline Hires Ex-Astra Finance Boss Symonds As Chair

24th Jul 2019 10:34

(Alliance News) - GlaxoSmithKline PLC said Wednesday former AstraZeneca PLC finance chief Jonathan Symonds will replace outgoing Chair Philip Hampton at the FTSE 100-listed drugmaker from the of a Read More

Rio Tinto Appoints Novartis Legal Head As General Counsel Executive

1st Jul 2019 09:13

(Alliance News) - Rio Tinto PLC said Monday it has appointed Barbara Levi as group general counsel with effect from January 1, 2020.She will be replacing Philip Richards, who will retire in Read More

Vectura Gets Milestone Payment On Novartis Submission Of Asthma Drug

24th May 2019 09:35

LONDON (Alliance News) - Pharmaceutical company Vectura Group PLC said it is to receive a USD2.5 million milestone payment from Novartis AG relating to possible new asthma therapy filed a with EU Read More

Oxford BioMedica Notes Kymriah Cancer Treatment's Approval In Japan

26th Mar 2019 12:07

LONDON (Alliance News) - Gene and cell therapy firm Oxford BioMedica PLC on Tuesday noted a drug which uses one of its products has been approved in Japan.Oxford BioMedica is the sole of in Read More

Beximco Pharmaceuticals Acquires 14 New Drug Applications From Sandoz

20th Feb 2019 10:25

LONDON (Alliance News) - Bangladeshi pharmaceutical firm Beximco Pharmaceuticals Ltd said on Wednesday it has agreed to acquire a portfolio of eight Abbreviated New Drug Applications from Sandoz a Read More

FTSE 100 Latest
Value7,967.76
Change35.78

Login to your account

Forgot Password?

Not Registered